Jefferies Financial Group Inc. Immunic, Inc. Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.98 - $1.44 $325,138 - $477,754
331,774 New
331,774 $368,000
Q4 2022

Sep 21, 2023
BUY
$1.13 - $10.8 $386,923 - $3.7 Million
342,410 New
342,410 $479,000
Q4 2022

Feb 14, 2023
BUY
$1.13 - $10.8 $386,923 - $3.7 Million
342,410 New
342,410 $479,000

Others Institutions Holding IMUX

# of Institutions
70
Shares Held
56.2M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.4M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email